{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:04:14Z","timestamp":1791198254097,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010120","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:00:00Z","timestamp":1410825600000}}],"reference-count":74,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010120.pub2","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T14:19:03Z","timestamp":1410877143000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Non-steroidal anti-inflammatory drugs for acute gout"],"prefix":"10.1002","author":[{"given":"Caroline MPG","family":"van Durme","sequence":"first","affiliation":[{"name":"Centre Hospitalier Universitaire de Li\u00e8ge; Department of Rheumatology; Avenue de l'Hopital 1 Li\u00e8ge Belgium 4000"},{"name":"Maastricht University Medical Center; Department of Internal Medicine; P. Debyeplein 15 Maastricht Limburg Netherlands 6201 AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir D","family":"Wechalekar","sequence":"additional","affiliation":[{"name":"Repatriation General Hospital; Rheumatology Unit; Daws Road Daw Park South Australia Australia 5041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Buchbinder","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University; Monash Department of Clinical Epidemiology, Cabrini Hospital; Suite 41, Cabrini Medical Centre 183 Wattletree Road Malvern Victoria Australia 3144"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Schlesinger","sequence":"additional","affiliation":[{"name":"UMDNJ - Robert Wood Johnson Medical School; Division of Rheumatology; MEB 474 New Brunswick NJ USA 08903-0019"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e","family":"van der Heijde","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Department of Rheumatology; PO Box 9600 Leiden Netherlands 2300 RC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert BM","family":"Landew\u00e9","sequence":"additional","affiliation":[{"name":"Academic Medical Center, University of Amsterdam; Department of Clinical Immunology and Rheumatology; Amsterdam Netherlands"},{"name":"Atrium Medical Centre; Department of Rheumatology; Herleen Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,9,16]]},"reference":[{"key":"10.1002\/14651858.CD010120.pub2-BIB0001|cit1","first-page":"1422","article-title":"Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study","volume":"15","author":"Altman","year":"1988","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.1780310618","article-title":"Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout","volume":"31","author":"Axelrod","year":"1988","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2125.1985.tb05110.x","article-title":"Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis","volume":"20","author":"Butler","year":"1985","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0149-2918(04)90035-5","article-title":"A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis","volume":"26","author":"Cheng","year":"2004","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0005|cit5","first-page":"275","article-title":"A comparison of phenylbutazone and flufenamic acid in the treatment of acute gout","volume":"10","author":"Douglas","year":"1970","journal-title":"Annals of Physical Medicine"},{"issue":"4A","key":"10.1002\/14651858.CD010120.pub2-BIB0006|cit6","first-page":"641","article-title":"Meclofenamate sodium in the treatment of acute gout. Results of a double-blind study","volume":"33","author":"Eberl","year":"1983","journal-title":"Arzneimittel-Forschung"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0007|cit7","first-page":"92","article-title":"A comparative, double-blind, parallel study with tenoxicam vs placebo in acute gouty arthritis","volume":"14","author":"Garcia de la Torre","year":"1987","journal-title":"Investigaci\u00f3n M\u00e9dica Internacional"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0140-6736(08)60799-0","article-title":"Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial","volume":"371","author":"Janssens","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD010120.pub2-BIB0009|cit9","first-page":"540","article-title":"The treatment of acute gout arthritis. Double-blind randomized comparative study between nimesulid and indomethacin","volume":"53","author":"Klumb","year":"1996","journal-title":"Revista Brasileira de Medicina"},{"issue":"6","key":"10.1002\/14651858.CD010120.pub2-BIB0010|cit10","first-page":"344","article-title":"A double-blind comparison of etodolac (Lodine) and high doses of naproxen in the treatment of acute gout","volume":"7","author":"Lederman","year":"1990","journal-title":"Advances in Therapy"},{"issue":"3A","key":"10.1002\/14651858.CD010120.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0002-9343(86)90131-2","article-title":"Flurbiprofen in the treatment of acute gout. A comparison with indomethacin","volume":"80","author":"Lomen","year":"1986","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1185\/03007999109111513","article-title":"Effectiveness of etodolac ('Lodine') compared with naproxen in patients with acute gout","volume":"12","author":"Maccagno","year":"1991","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.annemergmed.2006.11.014","article-title":"Comparison of oral prednisolone\/paracetamol and oral indomethacin\/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial","volume":"49","author":"Man","year":"2007","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/art.20007","article-title":"Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial","volume":"50","author":"Rubin","year":"2004","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bmj.324.7352.1488","article-title":"Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis","volume":"324","author":"Schumacher","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3899\/jrheum.110916","article-title":"Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: a randomized controlled trial","volume":"39","author":"Schumacher","year":"2012","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0196-0644(95)70037-4","article-title":"Randomized double-blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis","volume":"26","author":"Shrestha","year":"1995","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0018|cit18","first-page":"535","article-title":"Double-blind trial: ketoprofen versus phenylbutazone in acute gouty arthritis (author's translation)","volume":"88","author":"Siegmeth","year":"1976","journal-title":"Wiener Klinische Wochenschrift"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.32.4.351","article-title":"Comparison of indomethacin and phenylbutazone in acute gout","volume":"32","author":"Smyth","year":"1973","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/ard.36.1.80","article-title":"Multicentre trial of naproxen and phenylbutazone in acute gout","volume":"36","author":"Sturge","year":"1977","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/ar4159","article-title":"Rilonacept in the treatment of acute gouty arthritis: a randomised, controlled clinical trial using indomethacin as the active comparator","volume":"15","author":"Terkeltaub","year":"2013","journal-title":"Arthritis Research & Therapy"},{"issue":"7","key":"10.1002\/14651858.CD010120.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/kem090","article-title":"Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout","volume":"46","author":"Willburger","year":"2007","journal-title":"Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD010120.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1003-5257(12)60007-5","article-title":"Comparative observation of therapeutic effects of acupuncture combined with infrared irradiation and western medicine on acute gouty arthritis","volume":"22","author":"Zhou","year":"2012","journal-title":"World Journal of Acupuncture"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0024|cit24","first-page":"111","article-title":"Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis","volume":"20","author":"Alloway","year":"1993","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2125.1988.tb03412.x","article-title":"Comparison of the natural history of untreated acute gouty arthritis vs acute gouty arthritis treated with non-steroidal-anti-inflammatory drugs","volume":"26","author":"Arnold","year":"1988","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"45","key":"10.1002\/14651858.CD010120.pub2-BIB0026|cit26","first-page":"1696","article-title":"The acute gout attack","volume":"30","author":"Bach","year":"1979","journal-title":"Medizinische Welt"},{"issue":"4","key":"10.1002\/14651858.CD010120.pub2-BIB0027|cit27","first-page":"156","article-title":"Treatment of acute uric arthritis using perclusone","volume":"20","author":"Cunovic","year":"1973","journal-title":"Reumatizam"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/03009747309097100","article-title":"Treatment of acute attacks of gout with naproxen-C 1674","volume":"2","author":"Cuq","year":"1973","journal-title":"Scandinavian Journal of Rheumatology Supplement"},{"issue":"5","key":"10.1002\/14651858.CD010120.pub2-BIB0029|cit29","first-page":"35","article-title":"Comparison of the time to analgetic and anti-inflammatory effect in the treatment of gouty arthritis with nimesulide and sodium diclofenac","volume":"79","author":"Kudaeva","year":"2007","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1185\/030079907X210750","article-title":"Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout","volume":"23","author":"Navarra","year":"2007","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0031|cit31","unstructured":"Wortmann R Apremilast therapy for acute gouty arthritis ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1185\/03007998009109465","article-title":"Double-blind trial of feprazone and phenylbutazone in acute gout","volume":"6","author":"Reardon","year":"1980","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/03009747809095668","article-title":"Treatment of acute gouty arthritis with proquazone and indomethacin. A comparative, double-blind trial","volume":"21","author":"Ruotsi","year":"1978","journal-title":"Scandinavian Journal of Rheumatology Supplement"},{"issue":"3","key":"10.1002\/14651858.CD010120.pub2-BIB0034|cit34","first-page":"111","article-title":"Piroxicam in treatment of acute gout high dose versus low dose","volume":"68","author":"Tumrasvin","year":"1985","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"2","key":"10.1002\/14651858.CD010120.pub2-BIB0035|cit35","first-page":"133","article-title":"Use of tenoxicam in patients with acute gouty arthritis","volume":"9","author":"Valdes","year":"1987","journal-title":"European Journal of Rheumatology & Inflammation"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/art.1780220420","article-title":"Double-blind study of fenoprofen versus phenylbutazone in acute gouty arthritis","volume":"22","author":"Weiner","year":"1979","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0037|cit37","first-page":"248","article-title":"Corticosteroid therapy for the treatment of acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs","volume":"63","author":"Werlen","year":"1996","journal-title":"Revue du Rhumatisme (English ed.)"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2165\/00003495-198800351-00016","article-title":"Clinical experiences with the intramuscular injection of tiaprofenic acid in rheumatic diseases, with particular emphasis on time of onset and duration of the analgesic effect","volume":"35 Suppl 1","author":"Katona","year":"1988","journal-title":"Drugs"},{"issue":"5","key":"10.1002\/14651858.CD010120.pub2-BIB0039|cit39","first-page":"739","article-title":"Oxaprozin in patients with gout","volume":"27","author":"Monov","year":"2009","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0040|cit40","unstructured":"American College of Rheumatology 1977 criteria for the classification of acute arthritis of primary gout www.rheumatology.org\/practice\/clinical\/classification\/gout.asp"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2125.1987.tb03132.x","article-title":"Observations on spontaneous improvement in patients with podagra: implications for the therapeutic trials of non-steroidal anti-inflammatory drugs","volume":"24","author":"Bellamy","year":"1987","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1186\/ar1794","article-title":"Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance","volume":"7 Suppl 4","author":"Borer","year":"2005","journal-title":"Arthritis Research & Therapy"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0043|cit43","unstructured":"Cates CD Visual Rx NNT Calculator, 2007 www.nntonline.net\/"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0044|cit44","volume-title":"Statistical Power Analysis for the Behavorial Sciences","author":"Cohen","year":"1988"},{"issue":"11","key":"10.1002\/14651858.CD010120.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jama.292.11.1363","article-title":"Clinical trial registration: a statement from the International Committee of Medical Journal Editors","volume":"292","author":"DeAngelis","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0046|cit46","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD010120.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archinte.162.3.265","article-title":"Association of non-steroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study","volume":"162","author":"Feenstra","year":"2002","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010120.pub2-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003831","article-title":"Celecoxib for rheumatoid arthritis","author":"Garner","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD010120.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003685.pub2","article-title":"Rofecoxib for rheumatoid arthritis","author":"Garner","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010120.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3899\/jrheum.090371","article-title":"Progress in measurement instruments for acute and chronic gout studies","volume":"36","author":"Grainger","year":"2009","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0052|cit52","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0053|cit53","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0054|cit54","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD010120.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005521.pub2","article-title":"Systemic corticosteroids for acute gout","author":"Janssens","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD010120.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","article-title":"British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout","volume":"46","author":"Jordan","year":"2007","journal-title":"Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis?","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD010120.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis in acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care & Research"},{"issue":"12","key":"10.1002\/14651858.CD010120.pub2-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub2","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010120.pub2-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008952.pub2","article-title":"Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity","author":"Marks","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010120.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD010120.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1001124","article-title":"Gout","volume":"364","author":"Neogi","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1182\/blood.V91.5.1769","article-title":"Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes","volume":"91","author":"Pouliot","year":"1998","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0064|cit64","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/rheumatology\/kem150","article-title":"Is gout associated with reduced quality of life? A case-control study","volume":"46","author":"Rhody","year":"2007","journal-title":"Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD010120.pub2-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000396.pub3","article-title":"Non-steroidal anti-inflammatory drugs for low back pain","author":"Roelofs","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010120.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3899\/jrheum.090370","article-title":"Outcome domains for studies of acute and chronic gout","volume":"36","author":"Schumacher","year":"2009","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0069|cit69","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2007.081604","article-title":"Gout is associated with more comorbidities, poorer health-related quality of life and higher health-care utilization in US veterans","volume":"67","author":"Singh","year":"2006","journal-title":"Annals of Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0071|cit71","unstructured":"Sterne JAC Egger M Moher D Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010120.pub2-BIB0072|cit72","volume-title":"Criteria of Diagnosis and Therapeutic Effect of Diseases and Syndromes in Traditional Chinese Medicine","author":"State Administration of Traditional Chinese","year":"1994"},{"issue":"4","key":"10.1002\/14651858.CD010120.pub2-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003789.pub2","article-title":"Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis","author":"Wienecke","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010120.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Annals of Rheumatic Diseases"}],"updated-by":[{"DOI":"10.1002\/14651858.cd010120.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010120.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:40:31Z","timestamp":1628548831000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD010120.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Musculoskeletal Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,16]]},"references-count":74,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010120.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD010120.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,16]]}}}